AAAAAA

   
Results: 1-21 |
Results: 21

Authors: Xu, FJ Kilmarx, PH Supawitkul, S Limpakarnjanarat, K Manopaiboon, C Korattana, S Mastro, TD
Citation: Fj. Xu et al., Response to "Risk factors for HIV among northern Thai women: Testing hypotheses or repeating assumptions?" by David Gisselquist, J ACQ IMM D, 27(4), 2001, pp. 415-416

Authors: Xu, FJ Chen, HZ Li, ZH
Citation: Fj. Xu et al., Solid-state production of lignin peroxidase (LiP) and manganese peroxidase(MnP) by Phanerochaete chrysosporium using steam-exploded straw as substrate, BIORES TECH, 80(2), 2001, pp. 149-151

Authors: Luo, RZ Peng, HQ Xu, FJ Bao, JJ Pang, Y Pershad, R Issa, JPJ Liao, WSL Bast, RC Yu, YH
Citation: Rz. Luo et al., Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI, BBA-GENE ST, 1519(3), 2001, pp. 216-222

Authors: Xu, FJ Schillinger, JA Aubin, MR St Louis, ME Markowitz, LE
Citation: Fj. Xu et al., Sexually transmitted diseases of older persons in Washington State, SEX TRA DIS, 28(5), 2001, pp. 287-291

Authors: Wolfe, MI Xu, FJ Patel, P O'Cain, M Schillinger, JA St Louis, ME Finelli, L
Citation: Mi. Wolfe et al., An outbreak of syphilis in Alabama prisons: Correctional health policy andcommunicable disease control, AM J PUB HE, 91(8), 2001, pp. 1220-1225

Authors: van Haaften-Day, C Shen, Y Xu, FJ Yu, YH Berchuck, A Havrilesky, LJ de Bruijn, HWA van der Zee, AGJ Bast, RC Hacker, NF
Citation: C. Van Haaften-day et al., OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markersfor epithelial ovarian carcinoma - A critical appraisal, CANCER, 92(11), 2001, pp. 2837-2844

Authors: Xu, FJ Kilmarx, PH Supawitkul, S Yanpaisarn, S Limpakarnjanarat, K Manopaiboon, C Korattana, S Mastro, TD St Louis, ME
Citation: Fj. Xu et al., HIV-1 seroprevalence, risk factors, and preventive behaviors among women in northern Thailand, J ACQ IMM D, 25(4), 2000, pp. 353-359

Authors: Xu, FJ Leadon, SA Yu, YH Boyer, CM O'Briant, K Ward, K McWatters, A Zhao, XG Bae, DS DeSombre, K Zalutsky, MR Bast, RC
Citation: Fj. Xu et al., Synergistic interaction between anti-p185(HER-2) ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2, CLIN CANC R, 6(8), 2000, pp. 3334-3341

Authors: Bast, RC Yu, Y Xu, FJ Le, XF Mills, GB
Citation: Rc. Bast et al., Molecular approaches to management of epithelial ovarian cancer, INT J GYN C, 10, 2000, pp. 2-7

Authors: Kruzelock, RP Cuevas, BD Wiener, JR Xu, FJ Yu, YH Cabeza-Arvelaiz, Y Pershouse, M Lovell, MM Killary, AM Mills, GB Bast, RC
Citation: Rp. Kruzelock et al., Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer, ONCOGENE, 19(54), 2000, pp. 6277-6285

Authors: Luo, BH Xu, FJ Xie, YQ
Citation: Bh. Luo et al., Microstructure and internal friction of spray deposited Al-3.3Fe-10.7Si alloy, J MATER SCI, 35(1), 2000, pp. 109-113

Authors: Hogdall, EVS Hogdall, CK Tingulstad, S Hagen, B Nustad, K Xu, FJ Bast, RC Jacobs, IJ
Citation: Evs. Hogdall et al., Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass, INT J CANC, 89(6), 2000, pp. 519-523

Authors: Peng, HQ Xu, FJ Pershad, R Hunt, KK Frazier, ML Berchuck, A Gray, JW Hogg, D Bast, RC Yu, YH
Citation: Hq. Peng et al., ARHI is the center of allelic deletion on chromosome 1p31 ovarian and breast cancers, INT J CANC, 86(5), 2000, pp. 690-694

Authors: Xu, FJ Xia, WY Luo, RZ Peng, HQ Zhao, SL Dai, JY Long, Y Zou, LL Le, WD Liu, JS Parlow, AF Hung, MC Bast, RC Yu, YH
Citation: Fj. Xu et al., The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice, CANCER RES, 60(17), 2000, pp. 4913-4920

Authors: Xu, FJ Schillinger, JA Markowitz, LE Sternberg, MR Aubin, MR Louis, MES
Citation: Fj. Xu et al., Repeat Chlamydia trachomatis infection in women: Analysis through a surveillance case registry in Washington State, 1993-1998, AM J EPIDEM, 152(12), 2000, pp. 1164-1170

Authors: Xu, FJ Yu, YH Le, XF Boyer, C Mills, GB Bast, RC
Citation: Fj. Xu et al., The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression, CLIN CANC R, 5(11), 1999, pp. 3653-3660

Authors: Zalutsky, MR Xu, FJ Yu, Y Foulon, CF Zhao, XG Slade, SK Affleck, DJ Bast, RC
Citation: Mr. Zalutsky et al., Radioiodinated antibody targeting of the HER-2/neu oncoprotein: Effects oflabeling method on cellular processing and tissue distribution, NUCL MED BI, 26(7), 1999, pp. 781-790

Authors: Zhang, Z Barnhill, SD Zhang, H Xu, FJ Yu, YH Jacobs, I Woolas, RP Berchuck, A Madyastha, KR Bast, RC
Citation: Z. Zhang et al., Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses, GYNECOL ONC, 73(1), 1999, pp. 56-61

Authors: Yu, YH Xu, FJ Peng, HQ Fang, XJ Zhao, SL Li, Y Cuevas, B Kuo, WL Gray, JW Siciliano, M Mills, GB Bast, RC
Citation: Yh. Yu et al., NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas, P NAS US, 96(1), 1999, pp. 214-219

Authors: Boyer, CM Pusztai, L Wiener, JR Xu, FJ Dean, GS Bast, BS O'Briant, KC Greenwald, M DeSombre, KA Bast, RC
Citation: Cm. Boyer et al., Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185, INT J CANC, 82(4), 1999, pp. 525-531

Authors: Hogdall, EVS Hogdall, CK Kjaer, SK Xu, FJ Yu, YH Bast, RC Blaakaer, J Jacobs, IJ
Citation: Evs. Hogdall et al., OVX1 radioimmunoassay results are dependent on the method of sample collection and storage, CLIN CHEM, 45(5), 1999, pp. 692-694
Risultati: 1-21 |